This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kong, Y.
Right arrow Articles by Konieczny, S. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kong, Y.
Right arrow Articles by Konieczny, S. F.

Next Article 

Mol. Cell. Biol., Oct 1995, 5205-5213, Vol 15, No. 10
Copyright © 1995, American Society for Microbiology

Ras p21Val inhibits myogenesis without altering the DNA binding or transcriptional activities of the myogenic basic helix-loop-helix factors

Y Kong, SE Johnson, EJ Taparowsky and SF Konieczny
Department of Biological Sciences, Purdue University, West Lafayette, Indiana 47907-1392, USA.

MRF4, MyoD, myogenin, and Myf-5 are muscle-specific basic helix-loop- helix transcription factors that share the ability to activate the expression of skeletal muscle genes such as those encoding alpha-actin, myosin heavy chain, and the acetylcholine receptor subunits. The muscle regulatory factors (MRFs) also exhibit the unique capacity to initiate the myogenic program when ectopically expressed in a variety of nonmuscle cell types, most notably C3H10T1/2 fibroblasts (10T1/2 cells). The commitment of myoblasts to terminal differentiation, although positively regulated by the MRFs, also is controlled negatively by a variety of agents, including several growth factors and oncoproteins such as fibroblast growth factor (FGF-2), transforming growth factor beta 1 (TGF-beta 1), and Ras p21Val. The molecular mechanisms by which these varied agents alter myogenic terminal differentiation events remain unclear. In an effort to establish whether Ras p21Val represses MRF activity by directly targeting the MRF proteins, we examined the DNA binding and transcription activation potentials of MRF4 and MyoD when expressed in 10T1/2 cells or in 10T1/2 cells expressing Ras p21Val. Our results demonstrate that Ras p21Val inhibits terminal differentiation events by targeting the basic domain of the MRFs, and yet the mechanism underlying this inhibition does not involve altering the DNA binding or the inherent transcriptional activity of these regulatory factors. In contrast, FGF-2 and TGF-beta 1 block terminal differentiation by repressing the transcriptional activity of the MRFs. We conclude that the Ras p21Val block in differentiation operates via an intracellular signaling pathway that is distinct from the FGF-2 and TGF-beta 1 pathways.


This article has been cited by other articles:

  • van der Burgt, I., Kupsky, W., Stassou, S., Nadroo, A., Barroso, C., Diem, A., Kratz, C. P, Dvorsky, R., Ahmadian, M. R., Zenker, M. (2007). Myopathy caused by HRAS germline mutations: implications for disturbed myogenic differentiation in the presence of constitutive HRas activation. J. Med. Genet. 44: 459-462 [Abstract] [Full Text]  
  • Salem, M., Kenney, P. B., Rexroad, C. E. 3rd, Yao, J. (2006). Microarray gene expression analysis in atrophying rainbow trout muscle: a unique nonmammalian muscle degradation model. Physiol. Genomics 28: 33-45 [Abstract] [Full Text]  
  • Dogra, C., Changotra, H., Mohan, S., Kumar, A. (2006). Tumor Necrosis Factor-like Weak Inducer of Apoptosis Inhibits Skeletal Myogenesis through Sustained Activation of Nuclear Factor-{kappa}B and Degradation of MyoD Protein. J. Biol. Chem. 281: 10327-10336 [Abstract] [Full Text]  
  • Zhu, L., Tran, T., Rukstalis, J. M., Sun, P., Damsz, B., Konieczny, S. F. (2004). Inhibition of Mist1 Homodimer Formation Induces Pancreatic Acinar-to-Ductal Metaplasia. Mol. Cell. Biol. 24: 2673-2681 [Abstract] [Full Text]  
  • Wang, X., Thomson, S. R., Starkey, J. D., Page, J. L., Ealy, A. D., Johnson, S. E. (2004). Transforming Growth Factor {beta}1 Is Up-regulated by Activated Raf in Skeletal Myoblasts but Does Not Contribute to the Differentiation-defective Phenotype. J. Biol. Chem. 279: 2528-2534 [Abstract] [Full Text]  
  • Takahashi, C., Bronson, R. T., Socolovsky, M., Contreras, B., Lee, K. Y., Jacks, T., Noda, M., Kucherlapati, R., Ewen, M. E. (2003). Rb and N-ras Function Together To Control Differentiation in the Mouse. Mol. Cell. Biol. 23: 5256-5268 [Abstract] [Full Text]  
  • Mauro, A., Ciccarelli, C., De Cesaris, P., Scoglio, A., Bouche, M., Molinaro, M., Aquino, A., Zani, B. M. (2002). PKC{alpha}-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells. J. Cell Sci. 115: 3587-3599 [Abstract] [Full Text]  
  • Wyzykowski, J. C., Winata, T. I., Mitin, N., Taparowsky, E. J., Konieczny, S. F. (2002). Identification of Novel MyoD Gene Targets in Proliferating Myogenic Stem Cells. Mol. Cell. Biol. 22: 6199-6208 [Abstract] [Full Text]  
  • Johnson, S. E., Dorman, C. M., Bolanowski, S. A. (2002). Inhibition of myogenin Expression by Activated Raf Is Not Responsible for the Block to Avian Myogenesis. J. Biol. Chem. 277: 28742-28748 [Abstract] [Full Text]  
  • Liu, D., Black, B. L., Derynck, R. (2001). TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 15: 2950-2966 [Abstract] [Full Text]  
  • Oldham, J. M., Martyn, J. A. K., Sharma, M., Jeanplong, F., Kambadur, R., Bass, J. J. (2001). Molecular expression of myostatin and MyoD is greater in double-muscled than normal-muscled cattle fetuses. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280: R1488-R1493 [Abstract] [Full Text]  
  • Pena, T. L., Chen, S. H., Konieczny, S. F., Rane, S. G. (2000). Ras/MEK/ERK Up-regulation of the Fibroblast KCa Channel FIK Is a Common Mechanism for Basic Fibroblast Growth Factor and Transforming Growth Factor-beta Suppression of Myogenesis. J. Biol. Chem. 275: 13677-13682 [Abstract] [Full Text]  
  • Missero, C., Pirro, M. T., Di Lauro, R. (2000). Multiple Ras Downstream Pathways Mediate Functional Repression of the Homeobox Gene Product TTF-1. Mol. Cell. Biol. 20: 2783-2793 [Abstract] [Full Text]  
  • Rochard, P., Rodier, A., Casas, F., Cassar-Malek, I., Marchal-Victorion, S., Daury, L., Wrutniak, C., Cabello, G. (2000). Mitochondrial Activity Is Involved in the Regulation of Myoblast Differentiation through Myogenin Expression and Activity of Myogenic Factors. J. Biol. Chem. 275: 2733-2744 [Abstract] [Full Text]  
  • Winter, B, Arnold, H. (2000). Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J. Cell Sci. 113: 4211-4220 [Abstract]  
  • Adams, G. R., Haddad, F., Baldwin, K. M. (1999). Time course of changes in markers of myogenesis in overloaded rat skeletal muscles. J. Appl. Physiol. 87: 1705-1712 [Abstract] [Full Text]  
  • Lee, K. Y., Ladha, M. H., McMahon, C., Ewen, M. E. (1999). The Retinoblastoma Protein Is Linked to the Activation of Ras. Mol. Cell. Biol. 19: 7724-7732 [Abstract] [Full Text]  
  • Gallo, R., Serafini, M., Castellani, L., Falcone, G., Alemà, S. (1999). Distinct Effects of Rac1 on Differentiation of Primary Avian Myoblasts. Mol. Biol. Cell 10: 3137-3150 [Abstract] [Full Text]  
  • Kaliman, P., Canicio, J., Testar, X., Palacin, M., Zorzano, A. (1999). Insulin-like Growth Factor-II, Phosphatidylinositol 3-Kinase, Nuclear Factor-kappa B and Inducible Nitric-oxide Synthase Define a Common Myogenic Signaling Pathway. J. Biol. Chem. 274: 17437-17444 [Abstract] [Full Text]  
  • Wang, X., Peters, M. A., Utama, F. E., Wang, Y., Taparowsky, E. J. (1999). The Adrenomedullin Gene Is a Target for Negative Regulation by the Myc Transcription Complex. Mol. Endocrinol. 13: 254-267 [Abstract] [Full Text]  
  • Kang, J.-S., Mulieri, P. J., Miller, C., Sassoon, D. A., Krauss, R. S. (1998). CDO, A Robo-related Cell Surface Protein that Mediates Myogenic Differentiation. JCB 143: 403-413 [Abstract] [Full Text]  
  • Ramocki, M. B., White, M. A., Konieczny, S. F., Taparowsky, E. J. (1998). A Role for RalGDS and a Novel Ras Effector in the Ras-mediated Inhibition of Skeletal Myogenesis. J. Biol. Chem. 273: 17696-17701 [Abstract] [Full Text]  
  • Weyman, C. M., Wolfman, A. (1998). Mitogen-Activated Protein Kinase Kinase (MEK) Activity Is Required for Inhibition of Skeletal Muscle Differentiation by Insulin-Like Growth Factor 1 or Fibroblast Growth Factor 2. Endocrinology 139: 1794-1800 [Abstract] [Full Text]  
  • Takano, H., Komuro, I., Oka, T., Shiojima, I., Hiroi, Y., Mizuno, T., Yazaki, Y. (1998). The Rho Family G Proteins Play a Critical Role in Muscle Differentiation. Mol. Cell. Biol. 18: 1580-1589 [Abstract] [Full Text]  
  • Bennett, A. M., Tonks, N. K. (1997). Regulation of Distinct Stages of Skeletal Muscle Differentiation by Mitogen-Activated Protein Kinases. Science 278: 1288-1291 [Abstract] [Full Text]  
  • Eckner, R, Yao, T P, Oldread, E, Livingston, D M (1996). Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation.. Genes Dev. 10: 2478-2490 [Abstract]  
  • Kaliman, P., Vinals, F., Testar, X., Palacin, M., Zorzano, A. (1996). Phosphatidylinositol 3-Kinase Inhibitors Block Differentiation of Skeletal Muscle Cells. J. Biol. Chem. 271: 19146-19151 [Abstract] [Full Text]  
  • Dorman, C. M., Johnson, S. E. (2000). Activated Raf Inhibits Myogenesis through a Mechanism Independent of Activator Protein 1-mediated Myoblast Transformation. J. Biol. Chem. 275: 27481-27487 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»